ES2088661T3 - Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos. - Google Patents

Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos.

Info

Publication number
ES2088661T3
ES2088661T3 ES93900909T ES93900909T ES2088661T3 ES 2088661 T3 ES2088661 T3 ES 2088661T3 ES 93900909 T ES93900909 T ES 93900909T ES 93900909 T ES93900909 T ES 93900909T ES 2088661 T3 ES2088661 T3 ES 2088661T3
Authority
ES
Spain
Prior art keywords
bis
naftalimidas
cancerigenous
agents
etil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900909T
Other languages
English (en)
Inventor
Jung-Hui Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of ES2088661T3 publication Critical patent/ES2088661T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

ESTE INVENTO RELATA A LA BIS-NAFTALIMIDAS, QUE INCLUYEN 2,2 (1,2-ETANODIYLBIS(METILIMINO-2,1-ETANODYIL)-BIS(5-NITRO-1HBENZ(DE)ISOQUINOLEINA-1,3(2H)-DIONE), 2-(2-(N-METIL-N-(2-(2-(5-NITRO1,3-DIOXO-1H-BENZ(DE)ISOQUINOLEINA-2(3H)YL)ETIL)AMINO)ETIL)AMINO)ETIL)-5-NITRO-1H-BENZ(DE)ISOQUINOLEINA1,3(2H)-DIONE, 2,2 -(1,2-ETANODYILBIS(IMINO-2,1-ETANODYIL)-BIS(5NITRO-1H-BENZ(DE)ISOQUINOLEINA-1,3(2H)-DIONE), COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN, Y METODOS DE USARLOS PARA TRATAR CARCINOMAS DE TUMOR SOLIDO EN MAMIFEROS.
ES93900909T 1991-12-11 1992-12-11 Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos. Expired - Lifetime ES2088661T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80504591A 1991-12-11 1991-12-11

Publications (1)

Publication Number Publication Date
ES2088661T3 true ES2088661T3 (es) 1996-08-16

Family

ID=25190556

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900909T Expired - Lifetime ES2088661T3 (es) 1991-12-11 1992-12-11 Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos.

Country Status (8)

Country Link
US (1) US5488110A (es)
EP (1) EP0618901B1 (es)
JP (1) JPH07501822A (es)
AU (1) AU3241593A (es)
CA (1) CA2125142A1 (es)
DE (1) DE69211567T2 (es)
ES (1) ES2088661T3 (es)
WO (1) WO1993012092A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461176A (en) * 1991-03-27 1995-10-24 The Du Pont Merck Pharmaceutical Company Processes for preparing bis-naphthalimides containing amino-acid derived linkers
CA2125142A1 (en) * 1991-12-11 1993-06-24 Jung-Hui Sun Highly water soluble bis-naphthalimides useful as anticancer agents
IL110460A (en) * 1993-08-18 2001-01-11 Basf Ag Bis-naphthalimides, their preparation and pharmaceutical compositions containing them
WO1995008539A1 (en) * 1993-09-24 1995-03-30 The Du Pont Merck Pharmaceutical Company Improved methods for preparing bis-imide compounds
US5641782A (en) * 1995-02-16 1997-06-24 The Dupont Merck Pharmaceutical Company 3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
DE19720803A1 (de) * 1997-05-16 1998-11-19 Basf Ag Verfahren zur Herstellung von aromatischen Bisimiden
EP1020446B1 (en) * 1998-07-03 2006-03-15 Taiho Pharmaceutical Co., Ltd. Naphthalimidobenzamide derivatives
US20040070504A1 (en) * 2002-10-14 2004-04-15 Brollier Brian W. Semi-covert RFID enabled containers
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146720A (en) * 1976-10-27 1979-03-27 Laboratorios Made, S.A. N-aminoethyl-substituted-3-nitronaphthalimides
DE3481120D1 (de) * 1983-04-01 1990-03-01 Warner Lambert Co 3,6-disubstituierte-1,8-naphthalimide, verfahren zu ihrer herstellung und ihre verwendung.
DE3604827A1 (de) * 1986-02-15 1987-08-20 Bayer Ag Elektrophotographische toner
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
US5206250A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amide and thioamide linkers as anticancer agents
CA2125142A1 (en) * 1991-12-11 1993-06-24 Jung-Hui Sun Highly water soluble bis-naphthalimides useful as anticancer agents

Also Published As

Publication number Publication date
DE69211567T2 (de) 1996-10-10
JPH07501822A (ja) 1995-02-23
AU3241593A (en) 1993-07-19
EP0618901A1 (en) 1994-10-12
US5488110A (en) 1996-01-30
DE69211567D1 (de) 1996-07-18
WO1993012092A1 (en) 1993-06-24
CA2125142A1 (en) 1993-06-24
EP0618901B1 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
ES2193391T3 (es) Antagonistas muscarinicos.
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
ES2171884T3 (es) Compuestos de quinazolina.
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
NO931635L (no) Fremgangsmaate for fremstilling av kinazolin-derivater
MX9604145A (es) Metodos y composiciones utiles para la inhibicion de angiogenesis.
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
IL110131A0 (en) Arylidene and heteroarylidene oxindole derivatives, their preparation and pharmaceutical compositions containing them
ES2196377T3 (es) Derivados de naftiridina.
EA200100298A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5
DE69413523D1 (de) Benzimidazole derivate
MX9304482A (es) Mono-3-nitro-bis-naftalimidas asimetricas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
BR9805544A (pt) Uso de um composto.
UA41355C2 (uk) Засіб для лікування нейро-сніду
ES2166470T3 (es) Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a.
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
ES2088661T3 (es) Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos.
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
AR026267A1 (es) Agentes heterociclicos citotoxicos.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR013462A1 (es) Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 618901

Country of ref document: ES